Product Code: ETC6188160 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The testing and analytical services market in Australia is robust, catering to the growing complexity of pharmaceutical formulations and regulatory requirements. Services such as stability testing, bioanalytical studies, method validation, and impurity profiling are critical to ensuring drug safety and efficacy. Outsourcing of these services is rising among pharmaceutical and biotech firms seeking cost-efficiency and regulatory support.
The pharmaceutical testing and analytical services sector in Australia is expanding rapidly with increasing outsourcing trends. Services related to bioavailability, stability, and impurity profiling are in high demand. Theres also a marked trend toward advanced analytical techniques such as LC-MS/MS, spectroscopy, and chromatography, driven by the complexity of modern drug molecules and the need for regulatory compliance.
Testing and analytical services are constrained by the high cost of advanced analytical equipment and a shortage of highly trained analytical chemists. Regulatory pressure for validated methods and reproducible results adds complexity. Furthermore, the outsourcing of services often leads to longer turnaround times, which can affect drug development timelines.
Investment in analytical laboratories is facilitated through public-private partnerships and incentives for pharmaceutical quality assurance services. Australia`s reputation for high standards in pharmacovigilance and product validation draws global players to establish regional testing hubs, especially in biotech corridors such as Melbourne and Sydney.
Government policies encourage stringent testing and quality control under GMP and ICH Q3D guidelines, with the TGA overseeing compliance. There`s strong support for contract research and testing organizations through export market development grants and R&D tax offsets. These services are also critical to the TGA`s push for safer and more effective generics and biosimilars, which require extensive analytical comparison to originator products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Testing and Analytical Services Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Testing and Analytical Services Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Testing and Analytical Services Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Pharmaceutical Testing and Analytical Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pharmaceutical Testing and Analytical Services Market Trends |
6 Australia Pharmaceutical Testing and Analytical Services Market, By Types |
6.1 Australia Pharmaceutical Testing and Analytical Services Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Service Type, 2021- 2031F |
6.1.3 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Bioanalytical Testing, 2021- 2031F |
6.1.4 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Method Development & Validation, 2021- 2031F |
6.1.5 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Raw Material Testing, 2021- 2031F |
6.1.6 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Stability Testing, 2021- 2031F |
6.1.7 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Microbial Testing, 2021- 2031F |
6.1.8 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Pharmaceutical Testing and Analytical Services Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Medical Device Companies, 2021- 2031F |
6.2.3 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Pharmaceutical & Biopharmaceutical Companies, 2021- 2031F |
6.2.4 Australia Pharmaceutical Testing and Analytical Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Pharmaceutical Testing and Analytical Services Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Testing and Analytical Services Market Export to Major Countries |
7.2 Australia Pharmaceutical Testing and Analytical Services Market Imports from Major Countries |
8 Australia Pharmaceutical Testing and Analytical Services Market Key Performance Indicators |
9 Australia Pharmaceutical Testing and Analytical Services Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Testing and Analytical Services Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Australia Pharmaceutical Testing and Analytical Services Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Pharmaceutical Testing and Analytical Services Market - Competitive Landscape |
10.1 Australia Pharmaceutical Testing and Analytical Services Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Testing and Analytical Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |